Is BioWanze s.a. still active?

Yes, BioWanze s.a. is currently active.

What does BioWanze s.a. do?

BioWanze s.a.'s registered main activities are Manufacture of other organic basic chemicals and Manufacture of refined petroleum products and fossil fuel products. It is also registered for 2 additional activities.

Where is BioWanze s.a. registered?

BioWanze s.a.'s registered address is Rue Léon Charlier(WAN) 11, 4520 Wanze, Belgium.

How many employees does BioWanze s.a. have?

Based on its most recently filed annual accounts (fiscal year ending 28 Feb 2026), BioWanze s.a. reported 140.2 full-time equivalent employees.

What is BioWanze s.a.'s annual turnover?

BioWanze s.a.'s most recently filed annual turnover (fiscal year ending 28 Feb 2026) was €306,009,310.

Did BioWanze s.a. make a profit or a loss?

BioWanze s.a.'s most recently filed annual accounts (fiscal year ending 28 Feb 2026) reported a profit of €29,238,344.

When did BioWanze s.a. last file annual accounts?

BioWanze s.a.'s most recently filed annual accounts cover the fiscal year ending 28 Feb 2026.

Is BioWanze s.a. B Corp certified?

We have no B Corp certification on file for BioWanze s.a..

Does BioWanze s.a. hold Fairtrade certification?

No, BioWanze s.a. does not currently hold Fairtrade certification.

BioWanze s.a.

Q: When was BioWanze s.a. founded?

BioWanze s.a. was founded on 24 Jul 2006, making it 20 years old.

BE 0882.664.564

Copied!

NV/SA

Status

Active

Founded

24 Jul 2006 · 20 yrs

Size

Large · 140.2 FTE

Legal name

BIOWANZE

Main activity

Manufacture of other organic basic chemicals

Activities

4 activities

Manufacture of other organic basic chemicalsManufacture of refined petroleum products and fossil fuel productsManufacture of starches and starch productsManufacture of prepared feeds for farm animals

Financials

Turnover2026

€306M+0.2%

Profit / Loss2026

€29.2M-20.6%

Equity2026

€412M+7.6%

2026	2025	2024	2023
€306,009,310+0.2%	€305,327,812-18.8%	€376,179,940-7.2%	€405,281,280
€29,238,344-20.6%	€36,832,517-47.2%	€69,784,363-10.3%	€77,831,035
€411,582,481+7.6%	€382,543,721+10.5%	€346,093,139+25%	€276,867,347
€27,947,245+8.5%	€25,753,736-7.8%	€27,919,857-34.6%	€42,674,756
€4,268-38.5%	€6,941+40.2%	€4,952+440.6%	€916
140.2+0.5%	139.5+2.8%	135.7+2.9%	131.9
€2,182,663-0.3%	€2,188,730-21%	€2,772,144-9.8%	€3,072,640

Frequently asked questions

01What is BioWanze s.a.'s official registered name?

BIOWANZE.

02What is BioWanze s.a.'s enterprise number (VAT number)?

BE 0882.664.564.

03What is BioWanze s.a.'s legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was BioWanze s.a. founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

Financial statements

	2026	2025	2024	2023
Income statement
	€306,009,310+0.2%	€305,327,812-18.8%	€376,179,940-7.2%	€405,281,280
	140.2+0.5%	139.5+2.8%	135.7+2.9%	131.9
	€2,182,663-0.3%	€2,188,730-21%	€2,772,144-9.8%	€3,072,640
	€16,135,903+4.9%	€15,378,707+2.2%	€15,048,080+14.1%	€13,190,357
	€34,306,095-18.9%	€42,327,137-52.9%	€89,918,288-11%	€100,991,919
	€48,638,625	—	€111,118,860-8.4%	€121,321,953
	€43,786,875	—	€90,820,908-7.7%	€98,407,115
	€29,238,344-20.6%	€36,832,517-47.2%	€69,784,363-10.3%	€77,831,035
	€4,103,843-2.9%	€4,228,739+5.6%	€4,005,615-1.9%	€4,081,338
Profitability
	15.9%	—	29.5%-1.3%	29.9%
	9.6%-20.8%	12.1%-35%	18.6%-3.4%	19.2%
	7.1%-26.2%	9.6%-52.2%	20.2%-28.3%	28.1%
	6.6%-26.3%	9.0%-51.6%	18.7%-23.3%	24.3%
Solvency
	€439,883,925+7.7%	€408,435,657+9.2%	€374,131,766+17%	€319,824,899
	€151,311,944-2.9%	€155,885,785-8.8%	€170,981,223-3.7%	€177,485,884
	€43,0000%	€43,000-99.9%	€60,042,750>1000%	€42,750
	€411,582,481+7.6%	€382,543,721+10.5%	€346,093,139+25%	€276,867,347
	93.6%-0.1%	93.7%+1.3%	92.5%+6.9%	86.6%
	€27,947,245+8.5%	€25,753,736-7.8%	€27,919,857-34.6%	€42,674,756
	0.07+0.9%	0.07-16.5%	0.08-47.7%	0.15
	25.14-99.9%	38749.05>1000%	1231.58+300.8%	307.32
Liquidity
	€4,268-38.5%	€6,941+40.2%	€4,952+440.6%	€916
	€22,422,787+3.8%	€21,603,816-9.3%	€23,816,031-37.7%	€38,248,502
	€35,627,720+5.8%	€33,675,820-36.6%	€53,085,501+26.2%	€42,064,380
	€18,777,827+8.9%	€17,243,013-8.7%	€18,888,384-21.3%	€24,016,360
	€27,653,645+7.8%	€25,642,736-3.7%	€26,623,611-36%	€41,629,101
	4.01-59%	9.78+91.9%	5.10+53.1%	3.33
	€84,183,725-62.8%	€226,184,204+97.6%	€114,444,884+15.1%	€99,434,056
Efficiency
	43 days+5.6%	40 days-21.8%	52 days+36%	38 days
	26 days+7.6%	24 days-11.3%	27 days-7.8%	29 days
	34 days+2.8%	33 days-13.2%	38 days-23.7%	50 days
	10.94+4.1%	10.51+42.8%	7.36-12.3%	8.39
Profit appropriation
	—	—	—	€50,000,000
	€3,168,6000%	€3,168,6000%	€3,168,6000%	€3,168,600
	€223,668,547+15%	€194,430,203+23.4%	€157,597,686+79.5%	€87,813,323

Sources

NBB — Nationale Bank van België

	2026	2025	2024	2023
Income statement
	€306,009,310+0.2%	€305,327,812-18.8%	€376,179,940-7.2%	€405,281,280
	140.2+0.5%	139.5+2.8%	135.7+2.9%	131.9
	€2,182,663-0.3%	€2,188,730-21%	€2,772,144-9.8%	€3,072,640
	€16,135,903+4.9%	€15,378,707+2.2%	€15,048,080+14.1%	€13,190,357
	€34,306,095-18.9%	€42,327,137-52.9%	€89,918,288-11%	€100,991,919
	€48,638,625	—	€111,118,860-8.4%	€121,321,953
	€43,786,875	—	€90,820,908-7.7%	€98,407,115
	€29,238,344-20.6%	€36,832,517-47.2%	€69,784,363-10.3%	€77,831,035
	€4,103,843-2.9%	€4,228,739+5.6%	€4,005,615-1.9%	€4,081,338
Profitability
	15.9%	—	29.5%-1.3%	29.9%
	9.6%-20.8%	12.1%-35%	18.6%-3.4%	19.2%
	7.1%-26.2%	9.6%-52.2%	20.2%-28.3%	28.1%
	6.6%-26.3%	9.0%-51.6%	18.7%-23.3%	24.3%
Solvency
	€439,883,925+7.7%	€408,435,657+9.2%	€374,131,766+17%	€319,824,899
	€151,311,944-2.9%	€155,885,785-8.8%	€170,981,223-3.7%	€177,485,884
	€43,0000%	€43,000-99.9%	€60,042,750>1000%	€42,750
	€411,582,481+7.6%	€382,543,721+10.5%	€346,093,139+25%	€276,867,347
	93.6%-0.1%	93.7%+1.3%	92.5%+6.9%	86.6%
	€27,947,245+8.5%	€25,753,736-7.8%	€27,919,857-34.6%	€42,674,756
	0.07+0.9%	0.07-16.5%	0.08-47.7%	0.15
	25.14-99.9%	38749.05>1000%	1231.58+300.8%	307.32
Liquidity
	€4,268-38.5%	€6,941+40.2%	€4,952+440.6%	€916
	€22,422,787+3.8%	€21,603,816-9.3%	€23,816,031-37.7%	€38,248,502
	€35,627,720+5.8%	€33,675,820-36.6%	€53,085,501+26.2%	€42,064,380
	€18,777,827+8.9%	€17,243,013-8.7%	€18,888,384-21.3%	€24,016,360
	€27,653,645+7.8%	€25,642,736-3.7%	€26,623,611-36%	€41,629,101
	4.01-59%	9.78+91.9%	5.10+53.1%	3.33
	€84,183,725-62.8%	€226,184,204+97.6%	€114,444,884+15.1%	€99,434,056
Efficiency
	43 days+5.6%	40 days-21.8%	52 days+36%	38 days
	26 days+7.6%	24 days-11.3%	27 days-7.8%	29 days
	34 days+2.8%	33 days-13.2%	38 days-23.7%	50 days
	10.94+4.1%	10.51+42.8%	7.36-12.3%	8.39
Profit appropriation
	—	—	—	€50,000,000
	€3,168,6000%	€3,168,6000%	€3,168,6000%	€3,168,600
	€223,668,547+15%	€194,430,203+23.4%	€157,597,686+79.5%	€87,813,323

2026

2025

2024

2023

Income statement

€306,009,310+0.2%

€305,327,812-18.8%

€376,179,940-7.2%

€405,281,280

140.2+0.5%

139.5+2.8%

135.7+2.9%

131.9

€2,182,663-0.3%

€2,188,730-21%

€2,772,144-9.8%

€3,072,640

€16,135,903+4.9%

€15,378,707+2.2%

€15,048,080+14.1%

€13,190,357

€34,306,095-18.9%

€42,327,137-52.9%

€89,918,288-11%

€100,991,919

€48,638,625

—

€111,118,860-8.4%

€121,321,953

€43,786,875

—

€90,820,908-7.7%

€98,407,115

€29,238,344-20.6%

€36,832,517-47.2%

€69,784,363-10.3%

€77,831,035

€4,103,843-2.9%

€4,228,739+5.6%

€4,005,615-1.9%

€4,081,338

Profitability

15.9%

—

29.5%-1.3%

29.9%

9.6%-20.8%

12.1%-35%

18.6%-3.4%

19.2%

7.1%-26.2%

9.6%-52.2%

20.2%-28.3%

28.1%

6.6%-26.3%

9.0%-51.6%

18.7%-23.3%

24.3%

Solvency

€439,883,925+7.7%

€408,435,657+9.2%

€374,131,766+17%

€319,824,899

€151,311,944-2.9%

€155,885,785-8.8%

€170,981,223-3.7%

€177,485,884

€43,0000%

€43,000-99.9%

€60,042,750>1000%

€42,750

€411,582,481+7.6%

€382,543,721+10.5%

€346,093,139+25%

€276,867,347

93.6%-0.1%

93.7%+1.3%

92.5%+6.9%

86.6%

€27,947,245+8.5%

€25,753,736-7.8%

€27,919,857-34.6%

€42,674,756

0.07+0.9%

0.07-16.5%

0.08-47.7%

0.15

25.14-99.9%

38749.05>1000%

1231.58+300.8%

307.32

Liquidity

€4,268-38.5%

€6,941+40.2%

€4,952+440.6%

€916

€22,422,787+3.8%

€21,603,816-9.3%

€23,816,031-37.7%

€38,248,502

€35,627,720+5.8%

€33,675,820-36.6%

€53,085,501+26.2%

€42,064,380

€18,777,827+8.9%

€17,243,013-8.7%

€18,888,384-21.3%

€24,016,360

€27,653,645+7.8%

€25,642,736-3.7%

€26,623,611-36%

€41,629,101

4.01-59%

9.78+91.9%

5.10+53.1%

3.33

€84,183,725-62.8%

€226,184,204+97.6%

€114,444,884+15.1%

€99,434,056

Efficiency

43 days+5.6%

40 days-21.8%

52 days+36%

38 days

26 days+7.6%

24 days-11.3%

27 days-7.8%

29 days

34 days+2.8%

33 days-13.2%

38 days-23.7%

50 days

10.94+4.1%

10.51+42.8%

7.36-12.3%

8.39

Profit appropriation

—

€50,000,000

€3,168,6000%

€3,168,600

€223,668,547+15%

€194,430,203+23.4%

€157,597,686+79.5%

€87,813,323

BioWanze s.a.

Activities

Financials

Frequently asked questions

All locations

Financial statements

All locations

Financial statements